Drug metabolism and pancreatic cancer

RDF 

 
This item is provided by the institution :
Hellenic Society of Gastroenterology
Repository :
Annals of Gastroenterology
see item page
in the web site of the repository *
share



Drug metabolism and pancreatic cancer (EN)

Flores, John Paul E.
Diasio, Robert B.
Saif, Muhammad Wasif

Pancreatic cancer remains a fatal disease in the majority of patients. The era of personalized medicine is upon us: customizing therapy according to each patient's individual cancer. Potentially, therapy can be targeted at individuals who would most likely have a favorable response, making it more efficacious and cost effective. This is particularly relevant for pancreatic cancer, which currently portends a very poor prognosis. However, there is much to be done in this field, and more studies are needed to bring this concept to reality.Keywords Chemotherapy, genomic profile, genomics, molecular pancreatic pathogenesis, pancreatic cancer pharmacogenomics, pancreatic exocrine cancer, targeted therapyAnn Gastroenterol 2017; 30 (1): 54-61 (EN)

info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

Ελληνική Γαστροεντερολογική Εταιρία (EL)
Hellenic Gastroenterologiki Company (EN)

2016-12-27


Hellenic Society of Gastroenterology (EN)

1792-7463
1108-7471
Annals of Gastroenterology; Volume 30, No 1 (2017); 54 (EN)



*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)